☆Ally Bridge Group (NY) LLC
Quality Q
0.014
AUM ($M)
78
Positions
23
Turnover
0.52
Top-10 wt
65%
Herfindahl
0.065
History (qtrs)
6
Excess Return
not eligible
AI Eval Run AI Eval
Holdings · 31 positions · portfolio value $78M
| Ticker | Name | Activity | Security Type | Weight | Δ Weight | Value ($M) | Shares | Δ Shares | Qtrs Held | Excess Return |
|---|---|---|---|---|---|---|---|---|---|---|
| ☆NERV funds › | MINERVA NEUROSCIENCES INC | ADD | — | 15.6% | +5.7% | 12.1 | 2,175,802 | +520,302 | 2 | — |
| ☆PMN funds › | PROMIS NEUROSCIENCES INC | ADD | — | 10.5% | +5.3% | 8.2 | 620,319 | +206,100 | 2 | — |
| ☆TRAX funds › | FIRST TRACKS BIOTHERAPEUTICS | NEW | — | 7.4% | +7.4% | 5.7 | 284,287 | +284,287 | 1 | — |
| ☆AXSM funds › | AXSOME THERAPEUTICS INC | NEW | — | 5.2% | +5.2% | 4.0 | 16,493 | +16,493 | 1 | — |
| ☆ASMB funds › | ASSEMBLY BIOSCIENCES INC | NEW | — | 5.0% | +5.0% | 3.8 | 140,000 | +140,000 | 1 | — |
| ☆WHWK funds › | WHITEHAWK THERAPEUTICS INC | HOLD | Common Stock | 4.8% | +2.0% | 3.7 | 817,939 | +0 | 2 | — |
| ☆EWTX funds › | EDGEWISE THERAPEUTICS INC | TRIM | — | 4.4% | -0.7% | 3.4 | 83,300 | -77,700 | 2 | — |
| ☆CLYM funds › | CLIMB BIO INC | NEW | — | 4.2% | +4.2% | 3.2 | 249,172 | +249,172 | 1 | — |
| ☆KURA funds › | KURA ONCOLOGY INC | NEW | — | 4.1% | +4.1% | 3.2 | 290,000 | +290,000 | 1 | — |
| ☆CTMX funds › | CYTOMX THERAPEUTICS INC. | TRIM | — | 3.7% | -0.5% | 2.9 | 775,000 | -125,000 | 2 | — |
| ☆AVTX funds › | AVALO THERAPEUTICS INC | NEW | — | 3.6% | +3.6% | 2.8 | 150,000 | +150,000 | 1 | — |
| ☆PALI funds › | PALISADE BIO INC | NEW | — | 3.3% | +3.3% | 2.6 | 1,229,000 | +1,229,000 | 1 | — |
| ☆SLDB funds › | SOLID BIOSCIENCES INC | TRIM | — | 3.3% | -2.2% | 2.6 | 255,959 | -511,015 | 2 | — |
| ☆ANTX funds › | AN2 THERAPEUTICS INC | HOLD | — | 3.3% | +1.5% | 2.5 | 526,315 | +0 | 2 | — |
| ☆URGN funds › | UROGEN PHARMA LTD | TRIM | — | 3.3% | -0.3% | 2.5 | 69,183 | -132,941 | 2 | — |
| ☆CATX funds › | PERSPECTIVE THERAPEUTICS INC | TRIM | — | 3.3% | -0.6% | 2.5 | 743,958 | -182,599 | 2 | — |
| ☆IDYA funds › | IDEAYA BIOSCIENCES INC | NEW | — | 3.2% | +3.2% | 2.5 | 67,500 | +67,500 | 1 | — |
| ☆IVA funds › | INVENTIVA SA | TRIM | — | 3.1% | -1.0% | 2.4 | 634,800 | -110,500 | 2 | — |
| ☆ALMS funds › | ALUMIS INC | TRIM | — | 2.8% | -0.9% | 2.2 | 76,459 | -90,500 | 2 | — |
| ☆OVID funds › | OVID THERAPEUTICS INC | TRIM | — | 2.2% | -4.1% | 1.7 | 624,561 | -2,193,898 | 2 | — |
| ☆EPRX funds › | EUPRAXIA PHARMACEUTICALS INC | TRIM | — | 2.1% | -2.6% | 1.7 | 252,175 | -408,200 | 2 | — |
| ☆IBIO funds › | IBIO INC | NEW | — | 0.9% | +0.9% | 0.7 | 390,147 | +390,147 | 1 | — |
| ☆TRAW funds › | TRAWS PHARMA INC | NEW | — | 0.9% | +0.9% | 0.7 | 786,236 | +786,236 | 1 | — |
| ☆IKT funds › | INHIBIKASE THERAPEUTICS INC | EXIT | — | 0.0% | -2.2% | 0.0 | 0 | -1,325,000 | 0 | — |
| ☆RLMD funds › | RELMADA THERAPEUTICS INC | EXIT | — | 0.0% | -1.5% | 0.0 | 0 | -210,525 | 0 | — |
| ☆CUSIP:834203309 funds › | SOLENO THERAPEUTICS INC | EXIT | — | 0.0% | -6.7% | 0.0 | 0 | -200,000 | 0 | — |
| ☆CAPR funds › | CAPRICOR THERAPEUTICS INC | EXIT | — | 0.0% | -3.4% | 0.0 | 0 | -113,899 | 0 | — |
| ☆CMPS funds › | COMPASS PATHWAYS PLC | EXIT | — | 0.0% | -5.7% | 0.0 | 0 | -1,045,000 | 0 | — |
| ☆TARS funds › | TARSUS PHARMACEUTICALS INC | EXIT | — | 0.0% | -5.6% | 0.0 | 0 | -80,859 | 0 | — |
| ☆PRAX funds › | PRAXIS PRECISION MEDICINES I | EXIT | — | 0.0% | -10.5% | 0.0 | 0 | -32,810 | 0 | — |
| ☆ABVX funds › | ABIVAX SA | EXIT | — | 0.0% | -3.7% | 0.0 | 0 | -33,712 | 0 | — |
Point-in-time history
| Period | AUM ($M) | Positions | Turnover | Top-10 wt | Herfindahl | Quality Q | Skill | Universe |
|---|---|---|---|---|---|---|---|---|
| 2026Q2 | 78 | 23 | 0.52 | 65% | 0.065 | 0.014 | — | in |
| 2026Q1 | 101 | 21 | 0.43 | 65% | 0.058 | 0.041 | — | entered |
| 2025Q4 | 63 | 13 | 0.65 | 90% | 0.097 | 0.000 | — | out |
| 2025Q3 | 119 | 18 | 0.63 | 79% | 0.085 | 0.000 | — | left |
| 2025Q2 | 120 | 24 | 0.53 | 65% | 0.064 | 0.019 | — | entered |
| 2025Q1 | 111 | 28 | 0.00 | 65% | 0.054 | 0.000 | — | out |
Long US-equity 13F disclosures only · up to 45-day reporting lag · sells = reduce/avoid, not short.
JSON: /api/signals ·
/api/funds ·
/api/status